CNBCBiogen's stock rises 3% after company releases new data on late-stage Alzheimer's drugDec 5, 2019Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert